Recent Article Validates Tools ReGen Biologics, Inc. Uses To Measure Meniscus Performance

FRANKLIN LAKES, N.J.--(BUSINESS WIRE)--May 3, 2006--ReGen Biologics recognizes an important peer reviewed journal article which provides scientific validity for two important measures of patient status post-meniscus surgery. A torn meniscus is a common ailment, leading to approximately one million surgeries in the United States in 2005. Approximately 85% of these patients will undergo a partial meniscectomy, a procedure to remove the torn or damaged meniscus tissue, leaving them with less than original meniscus volume.
MORE ON THIS TOPIC